Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. 1995

A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305-5402, USA.

With the goal of examining the functional diversity of human immunodeficiency virus type 1 (HIV-1) env genes within the peripheral blood mononuclear cells of an asymptomatic individual, we substituted four complete env genes into the replication-competent NL4-3 provirus. Despite encoding full-length open reading frames for gp120 and gp41 and the second coding exon of tat and rev, each chimera was replication defective. Site-directed mutagenesis of codon 78 in the Rev activation domain (from a hitherto unique Ile to the subtype B consensus Leu) partially restored infectivity for two of three chimeras tested. Similarly, mutagenesis of rev codon 78 of NL4-3 from Leu to Ile partially attenuated this virus. Ile-78 was found in all 13 clones examined from samples taken from this asymptomatic subject 4.5 years after infection, including 9 from peripheral blood mononuclear cells and 4 from a virus isolate, as well as 4 additional clones each from peripheral blood mononuclear cells sampled 37 and 51 months later. We next examined conservation of the Rev activation domain within and among long-term survivors (LTS) and patients with AIDS, as well as T-cell-line-adapted strains of HIV-1. Putative attenuating mutations were found in a minority of sequences from all five LTS and two of four patients with AIDS. Of the 11 T-cell-line-adapted viruses examined, none had these changes. Among and within LTS virus population had marginally higher levels of diversity in Rev than in Env; patients with AIDS had similar levels of diversity in the two reading frames; and T-cell-line-adapted viruses had higher levels of diversity in Env. These results are consistent with the hypothesis that asymptomatic individuals harbor attenuated variants of HIV-1 which correlate with and contribute to their lack of disease progression.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA

Related Publications

A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
May 1995, FEBS letters,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
May 2009, The Journal of general virology,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
April 1991, Journal of virology,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
January 2018, Journal of laboratory physicians,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
June 1994, Journal of virology,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
January 1997, Clinical therapeutics,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
November 1989, DNA (Mary Ann Liebert, Inc.),
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
December 1988, Journal of virology,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
January 1996, The Journal of pediatrics,
A K Iversen, and E G Shpaer, and A G Rodrigo, and M S Hirsch, and B D Walker, and H W Sheppard, and T C Merigan, and J I Mullins
July 1995, Journal of virology,
Copied contents to your clipboard!